Search research articles
Contact Us
Filters
Showing results (431-440 of 448) with videos related to
Page
of 45
Sort By:
Healthcare (Amsterdam, Netherlands)
|
September 10, 2025
Enhanced obstetric training to address maternity care workforce shortages in tribal, rural, and underserved communities: a case from Oklahoma
Elizabeth Charron, Guimy Castor, Carrigan P Veach, et al.
Nature Biotechnology
|
May 27, 2026
Scoring gene importance by interpreting single-cell foundation models
Maxwell P Gold, Miguel Reyes, Nathaniel Diamant, et al.
Nature Neuroscience
|
May 7, 2025
Autonomic physiological coupling of the global fMRI signal
Taylor Bolt, Shiyu Wang, Jason S Nomi, et al.
JCO Precision Oncology
|
June 24, 2026
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study
Joyce O'Shaughnessy, Adam M Brufsky, Rakhshanda Layeequr Rahman, et al.
Hemasphere
|
August 7, 2024
The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
Andrew D Zelenetz, Wojciech Jurczak, Vincent Ribrag, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 7, 2006
Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses
Charles H Redfern, Troy H Guthrie, Alberto Bessudo, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
June 30, 2016
The ABMS MOC Part III Examination: Value, Concerns, and Alternative Formats
Richard E Hawkins, Mira Bjelotomich Irons, Catherine M Welcher, et al.
Cancer Letters
|
September 27, 2024
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma
Obada T Alhalabi, Mona Göttmann, Maxwell P Gold, et al.
Science Translational Medicine
|
September 6, 2023
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas
Pierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, et al.
Experimental Cell Research
|
August 15, 2001
Redefined nomenclature for members of the carcinoembryonic antigen family
N Beauchemin, P Draber, G Dveksler, et al.
Page
of 45
Search research articles
Search
Showing results (431-440 of 448) with videos related to
Sort By:
Page
of 45
Healthcare (Amsterdam, Netherlands)
|
September 10, 2025
Enhanced obstetric training to address maternity care workforce shortages in tribal, rural, and underserved communities: a case from Oklahoma
Elizabeth Charron, Guimy Castor, Carrigan P Veach, et al.
Nature Biotechnology
|
May 27, 2026
Scoring gene importance by interpreting single-cell foundation models
Maxwell P Gold, Miguel Reyes, Nathaniel Diamant, et al.
Nature Neuroscience
|
May 7, 2025
Autonomic physiological coupling of the global fMRI signal
Taylor Bolt, Shiyu Wang, Jason S Nomi, et al.
JCO Precision Oncology
|
June 24, 2026
Prediction of Anthracycline Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer by the MammaPrint 70-Gene Signature for Patients Enrolled in the FLEX Study
Joyce O'Shaughnessy, Adam M Brufsky, Rakhshanda Layeequr Rahman, et al.
Hemasphere
|
August 7, 2024
The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
Andrew D Zelenetz, Wojciech Jurczak, Vincent Ribrag, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 7, 2006
Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses
Charles H Redfern, Troy H Guthrie, Alberto Bessudo, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
June 30, 2016
The ABMS MOC Part III Examination: Value, Concerns, and Alternative Formats
Richard E Hawkins, Mira Bjelotomich Irons, Catherine M Welcher, et al.
Cancer Letters
|
September 27, 2024
Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma
Obada T Alhalabi, Mona Göttmann, Maxwell P Gold, et al.
Science Translational Medicine
|
September 6, 2023
Intratumoral drug-releasing microdevices allow in situ high-throughput pharmaco phenotyping in patients with gliomas
Pierpaolo Peruzzi, Christine Dominas, Geoffrey Fell, et al.
Experimental Cell Research
|
August 15, 2001
Redefined nomenclature for members of the carcinoembryonic antigen family
N Beauchemin, P Draber, G Dveksler, et al.
Page
of 45